Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome

被引:2
|
作者
Park, P. G. [1 ]
Pyo, J. Y. [1 ]
Ahn, S. S. [1 ]
Song, J. J. [1 ,2 ]
Park, Y-B [1 ,2 ]
Huh, J. H. [3 ]
Lee, S-W [1 ,2 ]
机构
[1] Yonsei Univ, Dept Internal Med, Div Rheumatol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
[3] Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Sacred Heart Hosp, Anyang, South Korea
关键词
antineutrophil cytoplasmic antibody; vasculitis; metabolic syndrome; components; all-cause mortality; CARDIOVASCULAR RISK; SCORE; DISEASE; ADULTS; INDEX; KOREA;
D O I
10.55563/clinexprheumatol/k4m3it
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study investigated the effect of the number of metabolic syndrome (MetS) components on all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) with MetS. Methods The medical records of 93 AAV patients with MetS were retrospectively reviewed. MetS was diagnosed when three or more the following MetS components for Asians were met: (i) increased waist circumference; ii) high blood pressure; (iii) hypertriglyceridaemia; (iv) low level of high-density lipoprotein (HDL)-cholesterol; and (v) impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM). All-cause mortality was defined as death owing to any aetiology. Results The median age was 61.4 years and 33 patients were men. Among 93 AAV patients with MetS, as the number of MetS components increased, the cumulative patient survival rate significantly decreased (p = 0.024). Compared to surviving AAV patients with MetS, deceased AAV patients with MetS were older, had higher Birmingham vasculitis activity score (BVAS) and Five-factor score (FFS), a lower frequency of IFG or T2DM, and a higher number of MetS components. In the multivariable Cox analysis, AAV patients with MetS who had all five MetS components were approximately 62 times more susceptible to all-cause mortality than those who had only three components. In terms of IFG or T2DM, patients with only IFG exhibited a significantly lower cumulative patients??? survival rate than those without. Conclusion The presence of many MetS components at the initial diagnosis of AAV was an independent and significant predictor of all-cause mortality in AAV patients with MetS.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 50 条
  • [1] Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Lee, Soo Bin
    Kwon, Hyeok Chan
    Kang, Mi Il
    Park, Yong-Beom
    Park, Jun Yong
    Lee, Sang-Won
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (02) : 291 - 302
  • [2] Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Soo Bin Lee
    Hyeok Chan Kwon
    Mi Il Kang
    Yong-Beom Park
    Jun Yong Park
    Sang-Won Lee
    Rheumatology International, 2022, 42 : 291 - 302
  • [3] Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients
    Hessels, Arno C.
    Sanders, Jan Stephan F.
    van de Ven, Annick A. J. M.
    Kroesen, Bart-Jan
    Lambeck, Annechien J. A.
    Rutgers, Abraham
    Stegeman, Coen A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (03): : 1004 - 1009
  • [4] The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
    Atas, Dilek Barutcu
    Atas, Halil
    Izgi, Tuba Nur
    Velioglu, Arzu
    Arikan, Hakki
    Oner, Fatma Alibaz
    Direskeneli, Haner
    Tuglular, Serhan
    Asicioglu, Ebru
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (07) : 1427 - 1434
  • [5] The prevalence of metabolic syndrome is increased in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
    Dilek Barutcu Atas
    Halil Atas
    Tuba Nur İzgi
    Arzu Velioglu
    Hakki Arikan
    Fatma Alibaz Oner
    Haner Direskeneli
    Serhan Tuglular
    Ebru Asicioglu
    International Urology and Nephrology, 2021, 53 : 1427 - 1434
  • [6] ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN
    Popescu, M. L.
    Predeteanu, D.
    Opris-Belinski, D.
    Balanescu, A.
    Berghea, F.
    Borangiu, A.
    Constantinescu, C.
    Groseanu, L.
    Ionescu, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S27 - S28
  • [7] Antineutrophil cytoplasmic antibody-associated vasculitis
    Konda, Raghunandan
    Rajasekaran, Arun
    Rizk, Dana V.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (05): : 503 - 511
  • [8] Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zhang, Yuqi
    Guo, Jinyan
    Zhang, Panpan
    Zhang, Lei
    Duan, Xiaoguang
    Shi, Xiaofei
    Guo, Nailiang
    Liu, Shengyun
    FRONTIERS IN MEDICINE, 2021, 8
  • [9] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
    Rich, Eric N.
    Brown, Kevin K.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 447 - 454
  • [10] Complement in antineutrophil cytoplasmic antibody-associated vasculitis
    Jun Yuan
    Min Chen
    Ming-Hui Zhao
    Clinical and Experimental Nephrology, 2013, 17 : 642 - 645